Micro RNA s differentially regulated in cardiac and skeletal muscle in health and disease: Potential drug targets?
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Summary: The identification of non‐coding RNA species, previously thought of as ‘junk’ DNA, adds a new dimension of complexity to the regulation of DNA, RNA and protein. Micro RNA s are short non‐coding RNA species that control gene expression, are dysregulated in settings of cardiac and skeletal muscle disease and have emerged as promising therapeutic targets. Micro RNA s specifically enriched in cardiac and skeletal muscle are called myomiRs and play an important role in cardiac pathology and skeletal muscle biology. Moreover, micro RNA profiles are altered in response to exercise and disease; thus, their potential as therapeutic drug targets is being widely explored. In the cardiovascular field, therapeutic inhibition of micro RNA s has been shown to be effective in improving cardiac outcome in preclinical cardiac disease models. Micro RNA s that promote skeletal muscle regeneration are attractive therapeutic targets in muscle wasting conditions where regenerative capacity is compromised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miRNAs are up- or down-regulated in response to stress during cardiac disorders37 and they are notorious for their pleiotropic action, affecting multiple genes in different tissues37.”
From Rheostatic Regulation of the SERCA/Phospholamban Membrane Protein Complex Using Non-Coding RNA and Single-Stranded DNA oligonucleotides (2015) · cites this paper as [37]
In the citing paper
“miRNAs are up- or down-regulated in response to stress during cardiac disorders37 and they are notorious for their pleiotropic action, affecting multiple genes in different tissues37.”
From Rheostatic Regulation of the SERCA/Phospholamban Membrane Protein Complex Using Non-Coding RNA and Single-Stranded DNA oligonucleotides (2015) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039 · cited 1×
“2).(12,13) In skeletal muscle, the transforming growth factor”
BackgroundClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180 · cited 1×
“including apoptosis, fibrosis and pressure overload-induced remodelling, where they have been implicated as either causative or protective in settings of cardiac stress.(2,40) Expression of miR1, the most abundant miRNA in the heart, is decreased in mouse models of pathological cardiac hypertrophy.”
BackgroundSkeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106
Functional screening identifies miRNAs inducing cardiac regeneration
Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029
A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance
van Rooij, E., Quiat, D., Johnson, B. A., Sutherland, L. B., Qi, X., Richardson, J. A., Kelm, R. J., & Olson, E. N. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.10.013 · Cited by 960
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955 · cited 1×
“Safety and efficacy of AAV-based delivery in clinical trials is promising, particularly with the development of strategies to overcome immune responses.(105,118) Our understanding of miRNA biology and therapeutics has expanded at a rapid rate; however, further research is required to facilitate the development of miRN…”
BackgroundMicroRNA-34a regulates cardiac ageing and function.
Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013) · Nature · doi:10.1038/nature11919 · Cited by 821
Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760
MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy
McCarthy, J. J., & Esser, K. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00932.2006 · Cited by 423
Davidsen, P. K., Gallagher, I. J., Hartman, J. W., Tarnopolsky, M. A., Dela, F., Helge, J. W., Timmons, J. A., & Phillips, S. M. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00901.2010 · Cited by 385 · cited 1×
“including increases in miR-451 and decreases in miR-26a, miR29a and miR-378.(91)”
BackgroundSweetman, D., Goljanek, K., Rathjen, T., Oustanina, S., Braun, T., Dalmay, T., & Münsterberg, A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.06.019 · Cited by 262
Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201109091 · Cited by 218
Self-citationRapamycin inhibits the growth and muscle-sparing effects of clenbuterol
Kline, W. O., Panaro, F. J., Yang, H., & Bodine, S. C. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00873.2006 · Cited by 177 · cited 1×
“Stimulation of the b-adrenoceptor signalling pathway in skeletal muscle promotes skeletal muscle hypertrophy(16) in a manner that is dependent on mammalian target of rapamycin (mTOR) signalling.(17) Although the targeting of this pathway can potentially yield beneficial effects on skeletal muscle growth and regenerati…”
BackgroundHudson, M. B., Woodworth-Hobbs, M. E., Zheng, B., Rahnert, J. A., Blount, M. A., Gooch, J. L., Searles, C. D., & Price, S. R. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00266.2013 · Cited by 137 · cited 1×
“it is thought that the loss of miR-23a in atrophic conditions can be manifested by selective packaging into exosomes.(81)”
BackgroundRottiers, V., Obad, S., Petri, A., McGarrah, R., Lindholm, M. W., Black, J. C., Sinha, S., Goody, R. J., Lawrence, M. S., deLemos, A. S., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006840 · Cited by 121
Research works printed but not linked: 102
- 10.1016/j.hlc.2011.11.002 · DOI
- 10.1146/annurev-physiol-030212-183737 · DOI · Paper page
- 10.1242/jcs.041723 · DOI · Paper page
- 10.1073/pnas.0602831103 · DOI · Paper page
- 10.1083/jcb.200603039 · DOI · Paper page
- 10.1016/B978-0-12-381510-1.00001-6 · doi:10.1016/b978-0-12-381510-1.00001-6
- 10.1016/j.pharmthera.2010.04.005 · DOI · Paper page
- 10.1002/dvdy.24036 · DOI · Paper page
- 10.1113/jphysiol.2009.172544 · DOI · Paper page
- 10.1152/japplphysiol.01091.2007 · DOI · Paper page
- 10.1016/j.ddstr.2013.10.001 · DOI
- 10.1172/JCI113951 · DOI
- 10.1172/JCI117929 · DOI · Paper page
- 10.1152/ajpendo.00175.2007 · DOI · Paper page
- 10.1111/j.1440-1681.2009.05312.x · DOI
- 10.1073/pnas.94.15.8121 · DOI · Paper page
- 10.1097/MAJ.0b013e318222e620 · DOI · Paper page
- 10.4155/fmc.13.196 · DOI · Paper page
- 10.1016/j.cell.2007.03.030 · DOI · Paper page
- 10.1101/gad.1738708 · DOI · Paper page
- 10.1161/CIRCRESAHA.111.248880 · DOI · Paper page
- 10.1126/science.1139089 · DOI · Paper page
- 10.1016/j.yjmcc.2012.01.020 · DOI
- 10.1093/eurheartj/ehs043 · DOI
- 10.1172/JCI36154 · DOI · Paper page
- 10.1038/nature13073 · DOI · Paper page
- 10.1111/j.1582-4934.2011.01307.x · DOI · Paper page
- 10.1074/jbc.M111.331751 · DOI
- 10.1074/jbc.M310405200 · DOI · Paper page
- 10.1161/CIRCHEARTFAILURE.112.966622 · DOI
- 10.1161/ATVBAHA.109.201988 · DOI · Paper page
- 10.1161/ATVBAHA.112.300137 · DOI
- 10.1161/CIRCRESAHA.113.300226 · DOI · Paper page
- 10.1073/pnas.0608791103 · DOI · Paper page
- 10.1038/nm1582 · DOI · Paper page
- 10.1161/01.RES.0000257913.42552.23 · DOI · Paper page
- 10.1128/MCB.01222-08 · DOI · Paper page
- 10.1038/nm.2282 · DOI · Paper page
- 10.1371/journal.pone.0019481 · DOI
- 10.1161/CIRCRESAHA.112.265736 · DOI
- 10.1083/jcb.200603008 · DOI · Paper page
- 10.1083/jcb.201006025 · DOI · Paper page
- 10.1083/jcb.200911036 · DOI · Paper page
- 10.1093/nar/gkl743 · DOI · Paper page
- 10.1038/ng1725 · DOI · Paper page
- 10.1083/jcb.200912093 · DOI · Paper page
- 10.1038/cddis.2013.462 · DOI · Paper page
- 10.1126/science.1181046 · DOI · Paper page
- 10.1093/hmg/ddq367 · DOI · Paper page
- 10.1074/jbc.M110.192625 · DOI · Paper page
- 10.1093/nar/gkn032 · DOI · Paper page
- 10.1038/ncb1373 · DOI · Paper page
- 10.1371/journal.pone.0007607 · DOI · Paper page
- 10.1074/jbc.M111.219006 · DOI · Paper page
- 10.1016/j.molcel.2009.08.008 · DOI · Paper page
- 10.1128/MCB.01009-10 · DOI · Paper page
- 10.1016/j.cell.2010.07.011 · DOI · Paper page
- 10.1016/j.biocel.2013.12.003 · DOI
- 10.1152/ajpcell.00142.2010 · DOI · Paper page
- 10.1128/MCB.01370-09 · DOI · Paper page
- 10.3945/jn.109.112797 · DOI
- 10.1111/apha.12228 · DOI
- 10.1371/journal.pone.0073589 · DOI
- 10.1242/jeb.079590 · DOI
- 10.1007/s11010-013-1692-9 · DOI
- 10.1186/1471-2474-12-115 · DOI
- 10.1371/journal.pone.0029173 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.109.879429 · DOI · Paper page
- 10.1074/jbc.M112.390369 · DOI · Paper page
- 10.1242/jcs.119966 · DOI
- 10.1074/jbc.M111.271270 · DOI · Paper page
- 10.1152/jappl.2001.90.5.1900 · DOI · Paper page
- 10.1152/physiolgenomics.00145.2010 · DOI · Paper page
- 10.1073/pnas.0805038105 · DOI · Paper page
- 10.1161/HYPERTENSIONAHA.110.168252 · DOI · Paper page
- 10.1249/MSS.0b013e31824e8a36 · DOI · Paper page
- 10.1007/s00421-013-2685-9 · DOI
- 10.1021/cb300001m · DOI · Paper page
- 10.1113/jphysiol.2010.189860 · DOI · Paper page
- 10.1152/ajpendo.90562.2008 · DOI · Paper page
- 10.1371/journal.pone.0070823 · DOI · Paper page
- 10.1152/japplphysiol.01141.2013 · DOI · Paper page
- 10.1152/ajpheart.00711.2013 · DOI · Paper page
- 10.1146/annurev-pharmtox-011613-135957 · DOI
- 10.1056/NEJMoa1209026 · DOI · Paper page
- 10.1073/pnas.1206432109 · DOI · Paper page
- 10.1371/journal.pone.0090337 · DOI
- 10.1016/j.cell.2012.03.029 · DOI · Paper page
- 10.1073/pnas.1208863110 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.111.030932 · DOI · Paper page
- 10.1161/CIRCRESAHA.111.244442 · DOI · Paper page
- 10.1074/jbc.M113.494716 · DOI
- Taulli R, 2009, The muscle‐specific microRNA miR‐206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation, J. Clin. Invest., 119, 2366
- 10.1016/j.ccr.2008.10.006 · DOI · Paper page
- 10.1111/j.1582-4934.2009.00898.x · DOI · Paper page
- 10.1101/gad.198085.112 · DOI · Paper page
- 10.1172/JCI62656 · DOI · Paper page
- 10.1038/mt.2012.35 · DOI · Paper page
- 10.1038/embor.2010.208 · DOI · Paper page
- 10.1083/jcb.201105013 · DOI
- 10.1161/CIRCRESAHA.111.247916 · DOI · Paper page
- 10.1172/JCI62837 · DOI
Cited by
Soller, K. J., Verardi, R., Jing, M., Abrol, N., Yang, J., Walsh, N., Vostrikov, V. V., Robia, S. L., Bowser, M. T., & Veglia, G. (2015) · Scientific Reports · doi:10.1038/srep13000 · Cited by 12
Metadata
- Authors
- Winbanks, C. E., Ooi, J. Y., Nguyen, S. S., McMullen, J. R., & Bernardo, B. C.
- Affiliations
- Baker IDI Heart and Diabetes Institute Monash University Melbourne Vic. Australia
- Venue
- Clinical and Experimental Pharmacology and Physiology
- Publisher
- Wiley
- Published
- 2014-09
- Volume
- 41
- Issue
- 9
- Pages
- 727-737
- ISSN
- 0305-1870
- 1440-1681
- Cited by
- 20
- References
- 16
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.